Cargando…

Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients

Optimal care for breast cancer patients undergoing aromatase inhibitor (AI) treatment is ensured when estradiol (E(2)) levels are adequately suppressed. To assess treatment efficacy accurately, it is important to measure the serum E(2) levels using a well validated assay method with high sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaque, Jenny, Macdonald, Heather, Brueggmann, Doerthe, Patel, Sherfaraz K, Azen, Colleen, Clarke, Nigel, Stanczyk, Frank Z
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599208/ https://www.ncbi.nlm.nih.gov/pubmed/23520572 http://dx.doi.org/10.1186/2193-1801-2-5

Ejemplares similares

Determination of estradiol and progesterone content in capsules and creams from compounding pharmacies
por: Stanczyk, Frank Z., et al.
Publicado: (2019)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy
por: Niravath, Polly, et al.
Publicado: (2017)

General practitioners in German metropolitan areas – distribution patterns and their relationship with area level measures of the socioeconomic status
por: Bauer, Jan, et al.
Publicado: (2016)

Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase Inhibitors
por: Gibb, Fraser W, et al.
Publicado: (2019)

Sexual dimorphism of brain aromatase activity in medaka: induction of a female phenotype by estradiol.
por: Melo, A C, et al.
Publicado: (2001)

Aromatase Derived Estradiol Within the Thalamus Modulates Pain Induced by Varicella Zoster Virus
por: Kramer, Phillip R., et al.
Publicado: (2018)

The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy
por: Punjani, Nahid, et al.
Publicado: (2021)

ODP540 Aromatase interacting partner in Breast (AIPB) regulates estradiol in human breast
por: Moffitt, Alyssa M, et al.
Publicado: (2022)

Gender disparities in high-quality research revealed by Nature Index journals
por: Bendels, Michael H. K., et al.
Publicado: (2018)

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients
por: Bertelsen, Bjørn-Erik, et al.
Publicado: (2021)

Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration
por: Nagao, Taeko, et al.
Publicado: (2009)

Joint Symptoms, Aromatase Inhibitor-Related Adverse Reactions, Are Indirectly Associated with Decreased Serum Estradiol
por: Honda, Junko, et al.
Publicado: (2011)

Corrigendum: Aromatase Derived Estradiol Within the Thalamus Modulates Pain Induced by Varicella Zoster Virus
por: Kramer, Phillip R., et al.
Publicado: (2019)

Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
por: Mokbel, Ramia, et al.
Publicado: (2006)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

Incidence of menopausal symptoms in postmenopausal breast cancer patients treated with aromatase inhibitors
por: Hong, Dongsheng, et al.
Publicado: (2017)

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
por: Cairns, Junmei, et al.
Publicado: (2020)

Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
por: Chen, Han, et al.
Publicado: (2020)

Melatonin stimulates aromatase expression and estradiol production in human granulosa-lutein cells: relevance for high serum estradiol levels in patients with ovarian hyperstimulation syndrome
por: Cheng, Jung-Chien, et al.
Publicado: (2020)

Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia
por: Perez-Sepulveda, Alejandra, et al.
Publicado: (2015)

Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-Analysis
por: Chen, Shanshan, et al.
Publicado: (2022)

Oral estrogen leads to falsely low concentrations of estradiol in a common immunoassay
por: Cirrincione, Lauren R, et al.
Publicado: (2022)

Estradiol Testing in the Exploration of Early Onset Puberty: Comparison of RIA and Chemiluminescence Immunoassay
por: Blin, Justine, et al.
Publicado: (2023)

The association between estradiol levels and cognitive function in postmenopausal women
por: Gholizadeh, Soheila, et al.
Publicado: (2018)

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers.
por: Yates, R. A., et al.
Publicado: (1996)

Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
por: Goss, Paul E, et al.
Publicado: (2007)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Gonnelli, Stefano, et al.
Publicado: (2008)

Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
por: Lomax, Anna J., et al.
Publicado: (2013)

Ovarian mucinous adenocarcinoma with functioning stroma in postmenopausal women: aromatase and SF-1 expressions
por: Hattori, Yuka, et al.
Publicado: (2015)

Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
por: Ahn, Sung Gwe, et al.
Publicado: (2014)

Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis: PDGF-BB mediated by estradiol in women
por: Tang, Lanhua, et al.
Publicado: (2017)

Effects of aromatase inhibitor therapy on adiposity and cardiometabolic health in postmenopausal women: a controlled cohort extension study
por: Cheung, Yee-Ming M, et al.
Publicado: (2023)

EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
por: Polyzos, N. P., et al.
Publicado: (2020)

Aromatase Deficiency, a Rare Syndrome: Case Report
por: Baykan, Emine Kartal, et al.
Publicado: (2013)

Aromatase Deficiency, a Rare Syndrome: Case Report
por: Pignatti, Elisa, et al.
Publicado: (2013)

A Case of Female Pseudohermaphroditism Caused by Aromatase Deficiency
por: Nagasaki, Keisuke, et al.
Publicado: (2004)

Progressive height increase in an adult patient: Aromatase Deficiency
por: Akçay, Seçkin, et al.
Publicado: (2023)

Novel three-dimensional in vitro models of ovarian endometriosis
por: Brueggmann, Doerthe, et al.
Publicado: (2014)

Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer
por: Kim, Ju-Yeon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_muce2jnf13dn8mdbg1qkjv3age